MiR-4284 inhibits sensitivity to paclitaxel in human ovarian carcinoma SKOV3ip1 and HeyA8 cells by targeting DMC1. Sun D, Shang D, Miao P, Jiang Z, et al. Anticancer Drugs 2022;33:701-709.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sun D, Shang D, Miao P, Jiang Z, et al. MiR-4284 inhibits sensitivity to paclitaxel in human ovarian carcinoma SKOV3ip1 and HeyA8 cells by targeting DMC1. Anticancer Drugs 2022;33:701-709.
PMID: 35946537